A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C
Giovanna Fattovich(University of Modena and Reggio Emilia), A. Tagger(University of Milan), E. Minola(Humanitas Gavazzeni), Pierangelo Rovere, Martina Felder(Ospedale di Bolzano), C. Paternoster, G. Mazzella(University of Bologna), C. Scattolini, A. Miracolo(University of Bologna), M. Pantalena, Caterina Rizzo(University of Pisa), S. Suppressa(Azienda Usl 8 Arezzo), Stefano Milani(University of Florence), P. Benedetti(Ospedale San Bortolo), Antonio Carlotto, I. Zagni, Paolo Costa(Azienda Ospedaliera Carlo Poma), Sergio Boccia(Arcispedale Sant'Anna), Angelo Rossini(Centro Universitário Barão de Mauá), M.L. Ribero(University of Milan), L. Lomonaco, M. Capanni(University of Florence), T. Bertin(Ospedale San Bortolo), C Ferrara(Presidio Ospedaliero), Massimo Giusti(Azienda Usl 8 Arezzo)
Cited by 27
Related Papers
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
ChatGPT and the rise of large language models: the new AI-driven infodemic threat in public health
|Frontiers in Public Health|2023|640